Last reviewed · How we verify
Nasal CO2
At a glance
| Generic name | Nasal CO2 |
|---|---|
| Sponsor | Capnia, Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Caracterization of the Combined Alterations in Respiration and aROUSal in Patients With Drug-resistant EpiLepsy (NA)
- Real-Time End-Tidal Carbon Dioxide Monitoring for Early Warning of Hypoxemia in Painless Gastrointestinal Endoscopy (NA)
- Gas Composition in the Hypopharynx During High-flow or Standard Oxygen Therapy Through Face Mask in Healthy Volunteers (NA)
- High-flow Nasal Cannula Versus Conventional Oxygen During Awake Tracheal Intubation With Difficult Airways (NA)
- Evaluation of Supraclavicular Brachial Plexus Blocks at Various Volumes: Impact on Optic Nerve Sheath Diameter (NA)
- Supraglottic Jet Oxygenation Ventilation During Hysteroscopic Surgery (NA)
- Respiratory and Real-time Dynamics in Exercise-Induced Paradoxical Vocal Fold Motion (EARLY_PHASE1)
- Stress Management Program (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nasal CO2 CI brief — competitive landscape report
- Nasal CO2 updates RSS · CI watch RSS
- Capnia, Inc. portfolio CI